# A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia

> **NCT07107334** · PHASE2 · RECRUITING · sponsor: **University of Florida** · enrollment: 20 (estimated)

## Conditions studied

- Endometrioid Endometrial Adenocarcinoma

## Interventions

- **DRUG:** Glucagon-like peptide 1 receptor agonist

## Key facts

- **NCT ID:** NCT07107334
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-07
- **Primary completion:** 2028-11
- **Final completion:** 2029-11
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07107334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07107334, "A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07107334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*